Kevin A. Hommel, PhD

Clinical Psychologist, Behavioral Medicine and Clinical Psychology

Director, Divisional Data Core

Associate Professor, UC Department of Pediatrics

Phone: 513-636-4336

Fax: 513-803-0415


Show All


Clinical Interests

Promotion of treatment adherence; self-management in pediatric chronic conditions

Research Interests

Adherence and self-management assessment methodology; behavioral treatment of nonadherence; promotion of self-management behavior; impact of adherence and self-management on health outcomes; quality of life in pediatric chronic conditions

Visit the Hommel Lab.


Dr. Hommel's research is currently funded by the National Institutes of Health: National Institute of Child Health and Human Development and National Institute of Diabetes and Digestive and Kidney Diseases. Many of his studies are focused on developing, testing (via randomized controlled trial), and optimizing behavioral treatments for nonadherence in inflammatory bowel disease (IBD), as well as examining the effects of nonadherence on disease outcomes and health-related quality of life (HRQoL). Dr. Hommel is also involved in studies that are aimed at developing HRQoL measures in functional gastrointestinal disorders (FGID) and eosinophilic esophagitis. He is a co-investigator on the PROTECT study, which is a multisite U01 study aimed at defining the rate of corticosteroid-free remission in pediatric patients with ulcerative colitis receiving standardized medical therapy.  Additionally, Dr. Hommel is a co-investigator on a multisite R01 study aimed at developing and testing a collaborative chronic care network (C3N) to improve treatment outcomes in children with IBD.

Dr. Hommel came to Cincinnati Children's Hospital Medical Center in 2008 from the Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine. He continues to collaborate with investigators at the Children's Hospital of Philadelphia as a site principal investigator on two studies funded by the NIDDK. The first is evaluating the efficacy of a low magnitude mechanical stimulus intervention to improve bone mineral density in children with Crohn's disease and the second is examining the effects of a novel lipid matrix supplement on choline status in children with cystic fibrosis.

Education and Training

BA: University of Central Oklahoma, 1996.

MS: Oklahoma State University,1999.

PhD: Oklahoma State University, 2002.

: Cincinnati Children's Hospital Medical Center, 2002.

Fellowship: Cincinnati Children's Hospital Medical Center, 2004.


View PubMed Publications


Open Source Science: Transforming Chronic Illness Care. Co-Investigator. National Institute of Diabetes and Digestive and Kidney Diseases / National Institute of Nursing Research. 2009 - 2014.

Telehealth Enhancement of Adherence to Medication in Pediatric IBD (TEAM Study). Principal Investigator. National Institutes of Health / National Institute of Child Health and Human Development. 2011 - 2016.

Predicting Response to Standard Pediatric Colitis Therapy: The PROTECT study. Co-Investigator. National Institute of Diabetes and Digestive and Kidney Diseases. 2012 - 2017.